← FDA Drug Approvals (Drugs@FDA)

NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT · Approved 2026-03-26

Drug application

FDA Application #

ANDA220483

Application type

Abbreviated New Drug Application (Generic)

Brand name

NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE

Generic name

Norepinephrine Bitartrate

Active ingredients

NOREPINEPHRINE BITARTRATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

SAGENT

First approval

2026-03-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown